Novanta Inc. (NOVT)
Stock Price Chart
Key Info
| Market Cap | 4.17B |
| Revenue (ttm) | 602.83M |
| Net Income (ttm) | 41.08M |
| Shares Out | 35.16M |
| EPS (ttm) | 1.15 |
| PE Ratio | 103.12 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | November 24 |
| Last Price | $118.59 |
| Previous Close | $115.87 |
| Change ($) | 2.72 |
| Change (%) | 2.35% |
| Day's Open | 116.72 |
| Day's Range | 115.16 - 119.24 |
| Day's Volume | 85,539 |
| 52-Week Range | 66.44 - 127.91 |
More Stats
| Market Cap | 4.17B |
| Enterprise Value | 4.29B |
| Earnings Date (est) | Mar 3, 2021 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 35.16M |
| Float | 34.21M |
| EPS (basic) | 1.16 |
| EPS (diluted) | 1.15 |
| FCF / Share | 3.39 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 0.97% |
| FCF Yield | 2.86% |
| Payout Ratio | n/a |
| Shares Short | 427,199 |
| Short Ratio | 5.99 |
| Short % of Float | 1.25% |
| Beta | 1.16 |
| PE Ratio | 103.12 |
| Forward PE | n/a |
| P/FCF Ratio | 34.99 |
| PS Ratio | 6.92 |
| PB Ratio | 8.93 |
| Revenue | 602.83M |
| Operating Income | 51.80M |
| Net Income | 41.08M |
| Free Cash Flow | 119.18M |
| Net Cash | -124.78M |
| Net Cash / Share | -3.55 |
| Gross Margin | 43.69% |
| Operating Margin | 8.59% |
| Profit Margin | 6.80% |
| FCF Margin | 19.77% |
| ROA | 4.59% |
| ROE | 9.62% |
| ROIC | 11.10% |
Analyst Forecasts
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 626 | 614 | 521 | 385 | 374 | 365 | 317 | 244 | 304 | 286 |
| Revenue Growth | 1.91% | 17.85% | 35.49% | 2.99% | 2.44% | 15.08% | 29.99% | -19.88% | 6.44% | - |
| Gross Profit | 262 | 262 | 221 | 162 | 158 | 150 | 132 | 106 | 133 | 131 |
| Operating Income | 55.28 | 71.01 | 57.57 | 32.96 | 28.93 | -16.81 | 19.45 | 20.26 | 35.85 | 9.87 |
| Net Income | 40.77 | 49.11 | 60.05 | 22.00 | 35.62 | -24.25 | 7.31 | 19.54 | 28.97 | -0.69 |
| Shares Outstanding | 35.03 | 34.91 | 34.82 | 34.69 | 34.58 | 34.35 | 34.07 | 33.78 | 33.48 | 23.70 |
| Earnings Per Share | 1.15 | 1.43 | 1.13 | 0.63 | 1.02 | -0.70 | 0.21 | 0.58 | 0.86 | -0.03 |
| EPS Growth | -19.58% | 26.55% | 79.37% | -38.24% | - | - | -63.79% | -32.56% | - | - |
| Operating Cash Flow | 63.25 | 89.65 | 63.38 | 47.79 | 33.42 | 42.29 | 49.20 | 28.43 | 45.17 | -4.74 |
| Capital Expenditures | -10.70 | -14.39 | -9.05 | -1.43 | -5.43 | -5.30 | -4.52 | -3.35 | -4.22 | -2.66 |
| Free Cash Flow | 52.55 | 75.26 | 54.33 | 46.36 | 27.99 | 36.99 | 44.68 | 25.08 | 40.96 | -7.40 |
| Cash & Equivalents | 78.94 | 82.04 | 100 | 68.11 | 59.96 | 51.15 | 60.98 | 65.79 | 54.84 | 56.78 |
| Total Debt | 260 | 207 | 235 | 77.92 | 95.81 | 112 | 71.50 | 50.00 | 68.00 | 108 |
| Net Cash / Debt | -181 | -125 | -135 | -9.81 | -35.85 | -61.23 | -10.52 | 15.79 | -13.17 | -50.79 |
| Assets | 870 | 720 | 727 | 426 | 416 | 396 | 379 | 337 | 349 | 367 |
| Liabilities | 453 | 351 | 368 | 167 | 171 | 185 | 136 | 109 | 139 | 188 |
| Book Value | 417 | 368 | 312 | 259 | 245 | 211 | 242 | 228 | 209 | 178 |
Company Profile
Company Details
| Full Name | Novanta Inc. |
| Country | United States |
| Employees | 2,290 |
| CEO | Matthijs Glastra |
Stock Information
| Ticker Symbol | NOVT |
| Stock Exchange | NASDAQ |
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Unique Identifier | NASDAQ: NOVT |
Description
Novanta, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The company's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless, recorder and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. Its Precision Motion segment offers optical and inductive encoders, precision motors, motion control sub-assemblies, servo drives, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Lincoln Laser, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, Celera Motion, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.